Kevin Tang - Sep 16, 2024 Form 4 Insider Report for Singular Genomics Systems, Inc. (OMIC)

Role
10%+ Owner
Signature
Kevin Tang
Stock symbol
OMIC
Transactions as of
Sep 16, 2024
Transactions value $
$1,806,220
Form type
4
Date filed
9/18/2024, 04:31 PM
Previous filing
Sep 23, 2024
Next filing
Dec 9, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OMIC Common Stock Purchase $642K +50.4K +20.2% $12.74 300K Sep 16, 2024 By LP F1, F2
transaction OMIC Common Stock Purchase $613K +40K +13.33% $15.33 340K Sep 17, 2024 By LP F2, F3
transaction OMIC Common Stock Purchase $551K +32K +9.41% $17.21 372K Sep 18, 2024 By LP F2, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The prices reported are weighted-average prices. These shares were purchased in multiple transactions at prices ranging from $11.55 to $13.25. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the SEC staff, upon request, all information regarding the number of shares purchased at each price within the ranges set forth in Footnotes 1, 3 and 4 herein.
F2 The shares are beneficially owned by Tang Capital Partners, LP ("TCP"). Kevin Tang is the sole manager of Tang Capital Management, LLC ("TCM"), which is the general partner of TCP. Mr. Tang has a pecuniary interest in the shares beneficially held by TCP.
F3 These shares were purchased in multiple transactions ranging from $13.04 to $17.22.
F4 These shares were purchased in multiple transactions ranging from $16.25 to $18.69.